SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-057690
Filing Date
2017-10-20
Accepted
2017-10-20 20:10:15
Documents
1
Period of Report
2017-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4739
  Complete submission text file 0001209191-17-057690.txt   6038
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Browne L Daniel (Reporting) CIK: 0001597583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 171147997